SUNRISE(SZ:002256)2025-01-24 12:35Financial Performance Projections - The estimated net profit for 2024 is projected to be a loss of between 106 million and 159 million CNY, compared to a loss of 84.82 million CNY in the same period last year[3] - The estimated operating revenue for 2024 is expected to be between 340 million and 350 million CNY, showing an increase from 331.08 million CNY in the previous year[3] - The basic earnings per share for 2024 are projected to be a loss of between 0.05 CNY and 0.08 CNY, compared to a loss of 0.04 CNY in the previous year[3] Cost Management - The company anticipates a significant reduction in financial expenses by 16 million CNY due to the repayment of high-interest debt[4] - Management expenses are expected to decrease by 20 million CNY after excluding the impact of stock incentive costs, indicating effective cost control measures[5] Equity and Investment - The company has transferred its equity in Shenzhen Small and Micro Enterprises Investment Management Co., Ltd., which is expected to reduce annual net profit by approximately 79 million CNY, but this is classified as a non-recurring loss[4] - The company has made provisions for bad debts related to the equity transfer payment from Qinghai Fuxing Mining Asset Management Co., Ltd., pending market value assessment[5] Strategic Focus - The company is focusing on two core sectors: "fine chemicals" and "photovoltaics," which are expected to enhance market competitiveness and stabilize revenue growth[4] Audit and Investor Advisory - The company has communicated with its auditing firm regarding the performance forecast, and there are no significant discrepancies noted[4] - Investors are advised to exercise caution as the performance forecast is a preliminary estimate and the final audited financial data will be disclosed in the 2024 annual report[5]